Assessing the benefit of the 72-hour antibiotic therapy reassessment documentation
Médecine et Maladies Infectieuses · 2019-05 · 49 (3) · 187-193
DOI: 10.1016/j.medmal.2018.10.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Médecine et Maladies Infectieuses, 2019-05. Verfasst von V Pérut und 11 weiteren Autor:innen. Beteiligte Einrichtung: Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France;…. Hauptthemen laut MEDLINE: Documentation, Medical Records. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: To assess the documentation of the 72-hour antibiotic therapy reassessment in medical records. METHODS: One-day prevalence evaluation of curative antibiotic therapies≥72hours. The documentation of the reassessment was defined according to three criteria: (1) "clear" documentation (clinical or microbiological comment associated with a comment on the need to adjust the antibiotic therapy or on the lack of need); (2) "tacit" documentation (only based on a clinical or microbiological comment); (3) no documentation. RESULTS: We assessed 114 antibiotic therapies in 26 hospital departments. A clear reassessment at 72hours was observed in only 45 (39%) records and 31 (27%) records had no reassessment. The planned duration of treatment was written in 63 (55%) records. At 72hours, among the 71 antibiotic therapies with a microbiological documentation, 69 (97%) were active and 44 (62%) had a narrow spectrum. Among the 48 antibiotic therapies with a broad spectrum on day 1, only 21 (44%) benefited from a de-escalation at 72hours. A clearly recorded reassessment at 72hours was associated with de-escalation (P=0.025) and the prescription of a planned duration of treatment was associated with antibiotic therapy compliance with local or national guidelines (P=0.018). CONCLUSION: Although reassessment was observed in 73% of records, it was correctly recorded at 72hours in only 39% of cases. The documentation of the reassessment and the prescription of a planned duration were associated with a better quality of antibiotic prescription (de-escalation, compliance with guidelines) and are relevant indicators for monitoring the proper use of antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Service de santé publique, unité de gestion des risques et qualité, h…
- Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Équipe mobile d'infectiologie, hôpitaux universitaires Paris centre,…
- Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Service de pharmacie des hôpitaux universitaires Paris centre, Assist…
- Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Unité d'information médicale, hôpitaux universitaires Paris centre, A…
- Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Service de bactériologie, hôpitaux universitaires Paris centre, Assis…
- Commission médicale des anti-infectieux (COMAI) des hôpitaux universitaires Paris centre, Assistance publique-Hôpitaux de Paris, 75014 Paris, France; Faculté de médecine, université Paris Descartes, Sorbonne Paris Cité,…
Zitieren
APA
Pérut, V., Gauzit, R., Kernéis, S., Canouï, E., Chedhomme, F. X., Batista, R., Conort, O., Bouam, S., Raymond, J., Loubinoux, J., Chevallier, A., & Salmon-Ceron, D. (2019). Assessing the benefit of the 72-hour antibiotic therapy reassessment documentation. Médecine et Maladies Infectieuses, 49(3), 187-193. https://doi.org/10.1016/j.medmal.2018.10.002
Vancouver
Pérut V, Gauzit R, Kernéis S, Canouï E, Chedhomme FX, Batista R, et al. Assessing the benefit of the 72-hour antibiotic therapy reassessment documentation. Médecine et Maladies Infectieuses. 2019;49(3):187-193. doi:10.1016/j.medmal.2018.10.002
BibTeX
@article{Prut2019,
author = {Pérut, V and Gauzit, R and Kernéis, S and Canouï, E and Chedhomme, F X and Batista, R and Conort, O and Bouam, S and Raymond, J and Loubinoux, J and Chevallier, A and Salmon-Ceron, D},
title = {Assessing the benefit of the 72-hour antibiotic therapy reassessment documentation},
journal = {Médecine et Maladies Infectieuses},
year = {2019},
volume = {49},
number = {3},
pages = {187--193},
doi = {10.1016/j.medmal.2018.10.002}
}
EUVIMED